ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research - Een podcast door American College of Cardiology - Dinsdagen
Categorieën:
The drug treatments we use to manage atrial fibrillation don't change the progression in the disease. Catheter ablation, even when performed in younger and healthier patients, modifies the disease trajectory and prevents progression. In this interview, Jason G. Andrade MD, FRCPC and Christopher M. Kramer MD, FACC discuss AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
